NCT04806594

Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.

Open Label, Uncontrolled Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar in the Prevention and Improvement of Scars and Lesions Associated With Acne

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Relife S.r.l. · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks and 3 clinical follow up visits will be performed.

Detailed description

The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks, 2 times per day into the face. The dermatologist will perform 3 clinical follow up visits to assess the efficacy and safety of the product.

Conditions

• Acne
• Scars

Interventions

Type	Name	Description
DEVICE	Papix acne scar	PapiX acne scar, class IIa medical device, gel for acne scar. to be applied 2 times per day during the 8 weeks of study duration

Timeline

• Start date: 2020-09-25
• Primary completion: 2021-07-01
• Completion: 2021-07-01
• First posted: 2021-03-19
• Last updated: 2025-01-08
• Results posted: 2025-01-08

Locations

1 site across 1 country: Italy